Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs. Risperidone in First Episode Psychosis (PAFIP3_3Y)
NCT03090503Phase 4Unknown
- Sponsor
- Fundación Marqués de Valdecilla
- Start
- Jun 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, risperidone in schizophrenia, psychotic disorder, psychosis, sponsored by Fundación Marqués de Valdecilla. Status: unknown.
02
Drugs
aripiprazolerisperidone
03
Conditions
schizophreniapsychotic disorderpsychosis
Beyond the preview
Go deeper on NCT03090503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090503.